Opioid Safety

Where’s the J&J that Managed the Tylenol Crisis? The Opioid Crisis, A Story of Corporate Mismanagement

Editor’s note: In this editorial from the desk of PPAHS’s Executive Director,  Johnson & Johnson could have taken a lead in the opioid crisis, but has chosen not to.

By Michael Wong, JD (Founder/Executive Director, Physician-Patient Alliance for Health & Safety)

Recently, Johnson & Johnson (J&J), a company that “believe(s) good health is the foundation of vibrant lives, thriving communities and forward progress,” was ordered to pay $572 million by Judge Thad Balkman of Cleveland County District Court in Oklahoma. Reported The New York Times about the judgment:

Read More